1. E. Domingo-Domenech
Information acquired: 2025
E. Domingo-Domenech is an academic who published a paper in 2022-08-25 entitled The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma☆. The paper was published in a journal entitled Annals of oncology : official journal of the European Society for Medical Oncology.